These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7536970)

  • 41. Germline VH gene usage in xenoreactive monoclonal antibody.
    Cramer DV; Wu GD; Borie DC; Shirwan H; Miller L; Makowka L
    Transplant Proc; 1996 Apr; 28(2):541-2. PubMed ID: 8623256
    [No Abstract]   [Full Text] [Related]  

  • 42. Hamster hearts transplanted to normal Lewis rats and RNU/RNU rats ("nude rats") are rejected at the same tempo but by different mechanisms.
    Nielsen B; Lillevang S; Salomon S; Steinbrüchel DA; Kemp E
    Transplant Proc; 1994 Jun; 26(3):1189-90. PubMed ID: 8029881
    [No Abstract]   [Full Text] [Related]  

  • 43. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
    Chong AS; Shen J; Xiao F; Blinder L; Foster P; Sankary H; Williams JW
    Transplant Proc; 1996 Apr; 28(2):684. PubMed ID: 8623344
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunosuppressive effect of soluble class I antigen and its complexes with monoclonal antibody on advanced heart graft rejection in rats.
    Sumimoto R; Kamada N
    Transplant Proc; 1991 Feb; 23(1 Pt 1):86-8. PubMed ID: 1990706
    [No Abstract]   [Full Text] [Related]  

  • 45. Splenectomy is a potent immunosuppressive modality for cardiac xenografting.
    Carobbi A; Araneda D; Thomas F; Quarantillo P; Thomas J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):419-20. PubMed ID: 8438360
    [No Abstract]   [Full Text] [Related]  

  • 46. Late CD8+ T cell-dependent xenoantibody production in innate tolerant nude rats after hamster islet grafting but not after hamster heart grafting.
    Devos T; Shengqiao L; Gysemans C; Yan Y; Damme BV; Nelson-Holte M; Billiau AD; Waer M; Mathieu C
    Transplantation; 2008 May; 85(10):1489-95. PubMed ID: 18497691
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolongation of hamster-to-rat cardiac xenograft survival by hyperimmune blood transfusion without immunosuppression.
    Lee PC; Lei HY; Hung CJ; Arakawa K; Oka T
    Transplant Proc; 1996 Jun; 28(3):1397-9. PubMed ID: 8658711
    [No Abstract]   [Full Text] [Related]  

  • 48. Rejection of hamster cardiac xenografts by rat CD4+ or CD8+ T cells.
    Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Anrather J; Bach FH
    Transplant Proc; 1999; 31(1-2):959-60. PubMed ID: 10083426
    [No Abstract]   [Full Text] [Related]  

  • 49. Prevention of sensitization and hyperacute rejection in liver and heart xenografts by FK 506 plus donor antigens.
    Tsugita M; Valdivia LA; Celli S; Pan F; Sun H; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):277. PubMed ID: 7533393
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetic evidence that the antibody response to xenografts is directed at a restricted number of target antigens.
    Wu GD; Cramer DV; Shirwan H; Borie D; Chapman FA
    Transplant Proc; 1997; 29(1-2):954. PubMed ID: 9123604
    [No Abstract]   [Full Text] [Related]  

  • 51. T-cell-mediated immune response is crucial for hamster-to-mouse cardiac xenograft rejection.
    Zhu T; Zhang L; Guo H; Luo YD; Xia SS; Chen ZK
    Transplant Proc; 2001; 33(7-8):3823. PubMed ID: 11750628
    [No Abstract]   [Full Text] [Related]  

  • 52. Anti-carbohydrate antibodies associated with hyperacute rejection in a vascularized mouse heart-to-rat xenotransplantation model.
    Gustavsson ML; Gannedahl G; Bäcker AE; Larson G; Olling A; Tufveson G; Samuelsson BE
    Transplantation; 1996 Mar; 61(6):957-63. PubMed ID: 8623166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accommodation of xenografts: expression of "protective genes" in endothelial and smooth muscle cells.
    Bach FH; Ferran C; Candinas D; Miyatake T; Koyamada N; Mark W; Hechenleitner P; Hancock WW
    Transplant Proc; 1997; 29(1-2):56-8. PubMed ID: 9123128
    [No Abstract]   [Full Text] [Related]  

  • 54. Rejection of cardiac xenografts by NK cells and macrophages.
    Lin Y; Goebels J; Vandeputte M; Waer M
    Transplant Proc; 1997 Aug; 29(5):2354. PubMed ID: 9270760
    [No Abstract]   [Full Text] [Related]  

  • 55. Hamster-to-rat cardiac xenografts. A useful model for transplantation studies.
    Kakita A; Blanchard J; Fortner JG
    J Surg Res; 1975 Aug; 19(2):99-106. PubMed ID: 1097829
    [No Abstract]   [Full Text] [Related]  

  • 56. Alpha 1,3galactosyltransferase: a target for in vivo genetic manipulation in xenotransplantation.
    Gustafsson K; Strahan K; Preece A
    Immunol Rev; 1994 Oct; 141():59-70. PubMed ID: 7532619
    [No Abstract]   [Full Text] [Related]  

  • 57. Avoiding compliance with histocompatibility dogma using immune privileged cell xenografts.
    Haider HKh; Lei Y; Jiang S; Law PK; Sim EK
    Ann Thorac Surg; 2003 Jul; 76(1):339-40; author reply 340. PubMed ID: 12842584
    [No Abstract]   [Full Text] [Related]  

  • 58. Comment concerning humoral rejection.
    Beletskaya LV; Baranova FS; Khalimova ZA
    J Heart Lung Transplant; 1992; 11(5):1009-12. PubMed ID: 1420230
    [No Abstract]   [Full Text] [Related]  

  • 59. [Xenogenic transplantation].
    Weill B; Houssin D
    Pediatrie; 1991; 46(4):309-11. PubMed ID: 1652735
    [No Abstract]   [Full Text] [Related]  

  • 60. The cellular rejection of xenografts--recent insights.
    Sebille F; Dorling A; Lechler RI
    Xenotransplantation; 2003 Jan; 10(1):4-6. PubMed ID: 12535219
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.